Synthesis, 5-Hydroxytryptamine1A Receptor Affinity and Docking Studies of 3-[3-(4-Aryl-1-piperazinyl)-propyl]-1H-Indole Derivatives

被引:11
|
作者
Pessoa-Mahana, Hernan [1 ]
Ugarte Nunez, Catalina [1 ]
Araya-Maturana, Ramiro [1 ]
Saitz Barria, Claudio [1 ]
Zapata-Torres, Gerald [2 ,3 ]
David Pessoa-Mahana, Carlos [4 ]
Iturriaga-Vasquez, Patricio [3 ,5 ]
Mella-Raipan, Jaime [4 ]
Reyes-Parada, Miguel [3 ,6 ,7 ]
Celis-Barros, Cristian [2 ]
机构
[1] Univ Chile, Fac Chem & Pharmaceut Sci, Dept Organ & Phys Chem, Santiago 1, Chile
[2] Univ Chile, Fac Chem & Pharmaceut Sci, Dept Analyt & Inorgan Chem, Santiago 1, Chile
[3] Millennium Inst Cell Dynam & Biotechnol, Santiago, Chile
[4] Pontificia Univ Catolica Chile, Fac Chem, Dept Pharm, Santiago 22, Chile
[5] Univ Chile, Fac Sci, Dept Chem, Santiago 1, Chile
[6] Univ Santiago Chile, Fac Med Sci, Sch Med, Santiago, Chile
[7] Univ Autonoma Chile, Fac Ciencias Salud, Santiago, Chile
关键词
indolylalkylarylpiperazine; 5-hydroxytryptamine(1A) receptor; docking; binding; synthesis; ARYLPIPERAZINE DERIVATIVES; SUBSTITUTED INDOLES; AUTOMATED DOCKING; 5-HT1A; SEROTONIN; AGONISTS; LIGANDS; ANTIDEPRESSANT; SELECTIVITY; INHIBITORS;
D O I
10.1248/cpb.60.632
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 3-[3-(4-aryl-1-piperazinyl)-propyl]-1H-indole derivatives (12a-h) was synthesized and evaluated for binding affinity at the human 5-hydroxytryptamine(1A) receptor (5-HT1AR) compounds (12b) and (12h) showed the highest 5-HT1A receptor affinity (IC50=15nM). Molecular docking studies with all the compounds in a homology model of 5-HT1A showed that the main interaction anchoring the ligand in the receptor was a charge-reinforced bond between the protonated nitrogen atom (N-4) of the piperazine ring and Aspartate(3.32).
引用
收藏
页码:632 / 638
页数:7
相关论文
共 50 条
  • [21] (R)-3-(N-methylpyrrolidin-2-ylmethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives as high affinity h5-HT1B/1D ligands
    Egle, I
    MacLean, N
    Demchyshyn, L
    Edwards, L
    Slassi, A
    Tehim, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (20) : 3419 - 3421
  • [22] NOVEL NONOPIOID NON-ANTIINFLAMMATORY ANALGESICS - 3-(AMINOALKYL) AND 3-[(4-ARYL-1-PIPERAZINYL)ALKYL]OXAZOLO[4,5-B]PYRIDIN-2(3H)-ONES
    FLOUZAT, C
    BRESSON, Y
    MATTIO, A
    BONNET, J
    GUILLAUMET, G
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (04) : 497 - 503
  • [23] The 2-hydroxy-3-(4-aryl-1-piperazinyl)propyl Phthalimide Derivatives as Prodrugs-Spectroscopic and Theoretical Binding Studies with Plasma Proteins
    Marciniak, Aleksandra
    Kotynia, Aleksandra
    Szkatula, Dominika
    Krzyzak, Edward
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [24] Effects of 1-[3-(4-benzhydryl-1-piperazinyl)propyl]-3-(1H-imidazol-1-ylmethyl)-1H-indole-6-carboxylic acid with thromboxane A(2) synthetase inhibitory and H-1-blocking activities on anaphylactic bronchospasm
    Nakamura, S
    Shirahase, H
    Kanda, M
    Wada, K
    Kamiya, S
    Matsui, H
    Kurahashi, K
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1996, 46 (11): : 1067 - 1071
  • [25] Design, Synthesis of 3-(5-Substituted Phenyl-[1,3,4]oxadiazol-2-yl)-1H-indole and Its Microbial Activity
    Suryawanshi, Manohar D.
    Suryawanshi, Ganesh D.
    Mhaske, Pravin C.
    Karpe, Dnyaneshwar G.
    Kamble, Komal R.
    Rode, Sagar J.
    Sudrik, Vilas A.
    Lawande, Shamrao P.
    CHEMISTRY & BIODIVERSITY, 2023, 20 (03)
  • [26] 3-[3-(Piperidin-1-yl)propyl] indoles as highly selective h5-HT1D receptor agonists
    Russell, MGN
    Matassa, VG
    Pengilley, RR
    van Niel, MB
    Sohal, B
    Watt, AP
    Hitzel, L
    Beer, MS
    Stanton, JA
    Broughton, HB
    Castro, JL
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (24) : 4981 - 5001
  • [27] Design, Synthesis, and Cytotoxicity Evaluation of 3-(5-(3-(aryl)-1-phenyl-1H-pyrazol-4-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)pyridine and 5-(3-(aryl)-1-phenyl-1H-pyrazol-4-yl)-3-(pyridin-3-yl)-4,5-dihydropyrazole-1-carbaldehyde Derivatives as Potential Anticancer Agents
    Alam, Raquib
    Alam, Md. Aftab
    Panda, Amulya K.
    Rahisuddin
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2017, 54 (03) : 1812 - 1821
  • [28] Synthesis and Antitumor Properties of 3-(2-Pyridine-3-vinyl)-1H-indole Dipyridine Ruthenium Complex
    Qian Xiao-Ting
    Lu Meng-Di
    Wang Qun
    Tao Qin
    Xue Xu-Ling
    Liu Hong-Ke
    CHINESE JOURNAL OF INORGANIC CHEMISTRY, 2021, 37 (05) : 824 - 834
  • [29] Synthesis, Pharmacological Properties, and Computational Study of 1-[3-(4-Aryl-1-piperazinyl)]propyl Derivatives of Amides of 7-Methyl-3-phenyl-2,4-dioxo-1 2,3,4-tetrahydropyrido[2,3-d]pyrimidine-5-carboxylic Acid
    Sabiniarz, A.
    Sladowska, H.
    Sapa, J.
    Filipek, B.
    Dudek, M.
    Godyn, G.
    Zyta, J.
    POLISH JOURNAL OF CHEMISTRY, 2009, 83 (05) : 981 - 998
  • [30] 5-HT1A and 5-HT2A receptor affinity and functional profile of some N-[3-(4-aryl-1-piperazinyl)propyl] derivatives of indolin-2(1H)-one, quinolin-2(1H)one and isoquinolin-1(2H)-one .30. Structure-activity relationship studies of CNS agents
    Mokrosz, MJ
    Mokrosz, JL
    Duszynska, B
    DerenWesolek, A
    Klodzinska, A
    Kowalski, P
    CharakchievaMinol, S
    Tatarczynska, E
    Kowalska, T
    Majka, Z
    ChojnackaWojcik, E
    Misztal, S
    PHARMAZIE, 1997, 52 (06): : 423 - 428